The SMARCB1 gene helps control which other genes are turned on or off, which supports normal cell growth and development. This gene plays an important role in keeping cell growth in check. If it does not work properly, cells may grow in a less controlled way, which can be linked to rhabdoid tumor predisposition syndrome, some cases of schwannomatosis, and a few other cancers. In families with a harmful SMARCB1 variant, genetic testing can sometimes help confirm the diagnosis.
What is a gene?
Genes are stretches of DNA that carry instructions cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which do much of the work inside cells. Others mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medications. More detail on this topic is available in the LearnHub.
Overview
SMARCB1Gene function
What if the gene works
The SMARCB1 gene helps control which genes cells turn on and off. This supports normal growth, development, and cell division, especially as tissues form and renew themselves.
Risk
What if the gene does not work
Variants in the SMARCB1 gene can cause rhabdoid tumor predisposition and may also be linked to schwannomatosis or a developmental condition called Coffin-Siris syndrome. Milder and more severe variants can affect which features appear, when they start, and their severity.
Treatment
What does that mean for your treatment
For some epithelioid sarcomas with loss of the SMARCB1 gene, the targeted medicine tazemetostat is an established option, especially when surgery is not suitable or the cancer has spread. Outside that setting, treatment usually follows the specific tumor type and stage rather than the SMARCB1 variant alone.
Conditions associated with SMARCB1
Gene function
What if the gene works
In everyday cell life, the SMARCB1 gene helps control how tightly DNA is packed and which instructions a cell can use. This supports steady growth, normal development, and the way cells take on their own roles. Understanding what the SMARCB1 gene does in your cells helps explain how your body keeps many basic cell tasks organized.
The SMARCB1 gene helps cells loosen or tighten packed DNA so important instructions can be reached. This makes it easier for a cell to use the right parts of its genetic code at the right time.
Through its protein, the SMARCB1 gene helps turn groups of genes on or off as needed. This keeps cell activity more orderly and matched to the cell’s job.
The SMARCB1 gene supports balanced cell growth and division. It helps cells move through these steps in a controlled way instead of drifting off schedule.
This gene helps cells mature into specific cell types and keep their specialized roles. That matters during early development and in the normal upkeep of many tissues.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SMARCB1 gene can change the protein’s stability or ability to join a complex that controls genes, reducing or removing its activity. This helps explain how SMARCB1 gene variants affect protein function: some single-letter changes leave partial activity, while variants that cut the protein short or delete the gene often stop the protein from being made. This spectrum can influence how strongly cell growth control is disrupted. More severe loss of function is linked to earlier disease onset.
How variants are linked to conditions
Among SMARCB1 gene disorders, the clearest cancer link is rhabdoid tumor predisposition syndrome, which can lead to rhabdoid tumors, including a rare brain tumor called atypical teratoid/rhabdoid tumor. Other pathogenic variants in the SMARCB1 gene can cause schwannomatosis, a condition with multiple nerve sheath tumors that often brings ongoing pain. A smaller group of variants is linked to Coffin-Siris syndrome, which affects development and learning.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. There are also cases in which a single well-characterized variant in a specific gene is sufficient to confirm a diagnosis.
Are there things that can increase or change my risk?
For SMARCB1, risk is usually driven mainly by the specific gene change itself, and it can vary by the exact variant and the pattern seen in your family. There is not enough evidence to say that lifestyle changes lower this inherited risk, so care usually focuses on monitoring and early detection.
Inheritance of SMARCB1 variants
SMARCB1-related conditions are usually inherited in an autosomal dominant pattern, which means a parent carrying a pathogenic variant in the SMARCB1 gene can pass it to each child with a 50% chance. This SMARCB1 gene inheritance pattern is seen in recognized conditions such as SMARCB1-related schwannomatosis and rhabdoid tumor predisposition syndrome. Some people have a new, de novo variant in the SMARCB1 gene, meaning it began in them and was not inherited from either parent. A person of any sex can inherit or pass on this variant.
What does my SMARCB1 result mean for my family?
A harmful change in the SMARCB1 gene is usually passed on in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same change and may want to learn whether it is present in them. In some families, the change starts new in one person, so it is not always inherited from a parent. The exact meaning for relatives can vary because SMARCB1 is linked to more than one recognized condition.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the SMARCB1 gene usually uses a blood or saliva sample. A lab reads the DNA code in the SMARCB1 gene and checks for extra, missing, or changed pieces. Results can show whether you carry a variant linked to an SMARCB1-related condition.
When should I consider getting a genetic test?
Genetic testing for the SMARCB1 gene may be worth discussing if you or your child has had a rhabdoid tumor, several nerve sheath tumors, or a strong family history of these growths. It can also help explain why certain rare tumors run in a family and whether relatives may also carry the change.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the kind of variant involved. Many factors, including age, environment, lifestyle, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, have little effect in another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics is an area of study that looks at how genetic differences affect the way people respond to medications. It examines connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This understanding can support treatment decisions that are both better informed and more individualized. For a deeper look at this subject, you can learn more in the LearnHub.
Drugs influenced by the SMARCB1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so general questions about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor. In cancer care, SMARCB1 changes in a tumor can sometimes be part of treatment planning, so people living with a SMARCB1-related cancer may want to review those results with their oncology team.
History
The SMARCB1 gene came into focus in the 1990s, when researchers studying aggressive childhood rhabdoid tumors found that many of these cancers had lost this gene. It was first described under names such as INI1 and SNF5 before SMARCB1 became the standard name in medical genetics. From these first observations, research expanded steadily. Scientists then recognized that changes in the SMARCB1 gene were also linked to other conditions, including schwannomatosis and several rare tumors. This work was important because it helped show that cancer can arise not only from changes in growth signals, but also from changes in how cells control access to genetic instructions. Over time, SMARCB1 became one of the key genes in the story of modern cancer genetics.